Abbott Laboratories

When researching Abbott Laboratories, analysts typically begin with its Health Care sector positioning and Health Care Equipment industry dynamics. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

The company reports trailing twelve-month revenue of $11.16B and net income of $1.08B. Key metrics include a return on equity of 2.1%.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for ABT to support both active traders and long-term investors.